Results for "Understanding Pharmaceutical Distribution"
Governor Hogan's Signing of Maryland Law Affirms Critical Role of PSAOs and Support for Independent Pharmacies
The Healthcare Distribution Alliance (HDA) issued the following statement today from President and CEO Chester “Chip” Davis, Jr., regarding the signing of SB 823 by Maryland Governor Larry Hogan.
HDA Statement on National Biodefense Strategy and Implementation Plan
The Healthcare Distribution Alliance (HDA) released the following statement in response to the Biden-Harris administration’s National Biodefense Strategy and Implementation Plan.
HDA Names Hannah Seitzinger Director of State Government Affairs
The Healthcare Distribution Alliance (HDA) announces the addition of Hannah Seitzinger as Director, State Government Affairs. In this role, Ms. Seitzinger will represent HDA’s healthcare distributor members in multiple states across the Midwest and report to Leah Lindahl, Vice President, State Government Affairs.
HDA Statement on FDA’s 12-digit National Drug Code Final Rule
The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Food and Drug Administration’s final rule expanding the National Drug Code (NDC) to a 12-digit format.
Faces of the Supply Chain: Distribution Sector Problem Solving and Cold Chain Capabilities
In the latest installment of HDA’s Faces of the Supply Chain series, HDA asked industry leaders to reflect on the role of healthcare distribution sector professionals as they navigate everyday challenges and adapt to evolving best practices as novel treatments emerge.
In part one of our two-part blog series, HDA is recapping the valuable perspectives shared during our conversations conducted at the 2024 Distribution Management Conference.